Home › Trial NCT01080066
A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)
- Trial IDNCT01080066
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorMerck KGaA, Darmstadt, Germany
- Enrollment215
- Start date2010-09
- ConditionsCarcinoma, Squamous Cell of Head and Neck
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.